SELLAS Life Sciences Group, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses5.1M4.7M4.2M3.9M3.2M4.4M4.4M5.2M
Operating Expenses9.3M8.3M7.1M6.9M6.1M6.9M7.3M7.6M
Operating Income-9.3M-8.3M-7.1M-6.9M-6.1M-6.9M-7.3M-7.6M
Other Income / Gains845K597K292K272K250K181K221K151K
Net Income-8.4M-7.7M-6.8M-6.6M-5.8M-6.7M-7.1M-7.5M
EPS (Diluted)-0.049-0.05-0.063-0.067-0.066-0.091-0.10-0.13
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses4.1M3.5M2.9M3.0M2.9M2.5M3.0M2.4M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses4.1M3.5M2.9M3.0M2.9M2.5M3.0M2.4M
Other Expenses00000000
Cost And Expenses9.3M8.3M7.1M6.9M6.1M6.9M7.3M7.6M
Interest Income845K597K292K272K250K181K221K151K
Interest Expense00000000
Depreciation And Amortization007.1M00000
Ebitda-8.4M-7.7M292K-6.6M-5.8M-6.7M-7.1M-7.5M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-8.4M-7.7M-6.8M-6.6M-5.8M-6.7M-7.1M-7.5M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.049-0.05-0.063-0.07-0.066-0.091-0.10-0.13
Weighted Average Shs Out172.5M153.1M108.4M94.3M87.8M74.0M68.3M57.5M
Weighted Average Shs Out Dil172.5M153.1M108.4M98.6M87.8M74.0M68.3M57.6M